195 related articles for article (PubMed ID: 35234213)
1. Combined clinical and specific positron emission tomography/computed tomography-based radiomic features and machine-learning model in prediction of thymoma risk groups.
Ozkan E; Orhan K; Soydal C; Kahya Y; Seckin Tunc S; Celik O; Dizbay Sak S; Kayi Cangir A
Nucl Med Commun; 2022 May; 43(5):529-539. PubMed ID: 35234213
[TBL] [Abstract][Full Text] [Related]
2. Role of flourine-18 fluorodeoxyglucose positron emission tomography in thymic pathology.
El-Bawab H; Al-Sugair AA; Rafay M; Hajjar W; Mahdy M; Al-Kattan K
Eur J Cardiothorac Surg; 2007 Apr; 31(4):731-6. PubMed ID: 17293120
[TBL] [Abstract][Full Text] [Related]
3. The efficacy of
Nakajo M; Takeda A; Katsuki A; Jinguji M; Ohmura K; Tani A; Sato M; Yoshiura T
Br J Radiol; 2022 Jun; 95(1134):20211050. PubMed ID: 35312337
[TBL] [Abstract][Full Text] [Related]
4. Radiomics based on
Ou X; Zhang J; Wang J; Pang F; Wang Y; Wei X; Ma X
Cancer Med; 2020 Jan; 9(2):496-506. PubMed ID: 31769230
[TBL] [Abstract][Full Text] [Related]
5. Use of fluorine-18 fluorodeoxyglucose positron emission tomography in the detection of thymoma: a preliminary report.
Liu RS; Yeh SH; Huang MH; Wang LS; Chu LS; Chang CP; Chu YK; Wu LC
Eur J Nucl Med; 1995 Dec; 22(12):1402-7. PubMed ID: 8586085
[TBL] [Abstract][Full Text] [Related]
6. The utility of [18F]-fluorodeoxyglucose positron emission tomography-computed tomography in thymic epithelial tumours.
Fukumoto K; Taniguchi T; Ishikawa Y; Kawaguchi K; Fukui T; Kato K; Matsuo K; Yokoi K
Eur J Cardiothorac Surg; 2012 Dec; 42(6):e152-6. PubMed ID: 23024234
[TBL] [Abstract][Full Text] [Related]
7. Interchangeability of radiomic features between [18F]-FDG PET/CT and [18F]-FDG PET/MR.
Vuong D; Tanadini-Lang S; Huellner MW; Veit-Haibach P; Unkelbach J; Andratschke N; Kraft J; Guckenberger M; Bogowicz M
Med Phys; 2019 Apr; 46(4):1677-1685. PubMed ID: 30714158
[TBL] [Abstract][Full Text] [Related]
8. Pretherapy 18F-fluorodeoxyglucose positron emission tomography/computed tomography robust radiomic features predict overall survival in non-small cell lung cancer.
Mostafa R; Abdelsamie Kandeel A; Abd Elkareem M; Nardo L; Abdelhafez YG
Nucl Med Commun; 2022 May; 43(5):540-548. PubMed ID: 35190518
[TBL] [Abstract][Full Text] [Related]
9. F-18 FDG PET/CT demonstration of thymoma followed by development of lung cancer.
Choi JJ; Ahn MI; Park MY; Jeon JS; Park YH
Clin Nucl Med; 2008 Mar; 33(3):234-5. PubMed ID: 18287859
[TBL] [Abstract][Full Text] [Related]
10. Machine learning in the differentiation of follicular lymphoma from diffuse large B-cell lymphoma with radiomic [
de Jesus FM; Yin Y; Mantzorou-Kyriaki E; Kahle XU; de Haas RJ; Yakar D; Glaudemans AWJM; Noordzij W; Kwee TC; Nijland M
Eur J Nucl Med Mol Imaging; 2022 Apr; 49(5):1535-1543. PubMed ID: 34850248
[TBL] [Abstract][Full Text] [Related]
11. Molecular subtype classification of breast cancer using established radiomic signature models based on
Liu J; Bian H; Zhang Y; Gao Y; Yin G; Wang Z; Li X; Ma W; Xu W
Front Biosci (Landmark Ed); 2021 Aug; 26(9):475-484. PubMed ID: 34590460
[No Abstract] [Full Text] [Related]
12. Positron emission tomography/computed tomography differentiates resectable thymoma from anterior mediastinal lymphoma.
Byrd CT; Trope WL; Bhandari P; Konsker HB; Moradi F; Lui NS; Liou DZ; Backhus LM; Berry MF; Shrager JB
J Thorac Cardiovasc Surg; 2023 Jan; 165(1):371-381.e1. PubMed ID: 35568521
[TBL] [Abstract][Full Text] [Related]
13. Use of radiomics based on
Zhou Y; Ma XL; Zhang T; Wang J; Zhang T; Tian R
Eur J Nucl Med Mol Imaging; 2021 Aug; 48(9):2904-2913. PubMed ID: 33547553
[TBL] [Abstract][Full Text] [Related]
14. Imaging of a case of metaplastic thymoma on 18F-FDG PET/CT.
Ishikawa Y; Kato K; Taniguchi T; Kawaguchi K; Yokoi K
Clin Nucl Med; 2013 Dec; 38(12):e463-4. PubMed ID: 24212449
[TBL] [Abstract][Full Text] [Related]
15. A diagnostic cohort study on the accuracy of 18-fluorodeoxyglucose (
Proli C; De Sousa P; Jordan S; Anikin V; Devaraj A; Love SM; Shackcloth M; Kostoulas N; Papagiannopoulos K; Haqzad Y; Loubani M; Sellitri F; Granato F; Bush A; Marchbank A; Iyer S; Scarci M; Lim E;
BMJ Open; 2018 Feb; 8(2):e019471. PubMed ID: 29437755
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the effect of PET/CT Fluorodeoxyglucose inclusion on mortality and survival in operated thymoma patients.
Agaoglu Sanli B; Duman E; Gulmez B; Aguloglu N; Yazgan S; Ceylan KC; Ucvet A
Nucl Med Commun; 2024 Mar; 45(3):236-243. PubMed ID: 38165166
[TBL] [Abstract][Full Text] [Related]
17. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
18. Role of fluorine-flurodeoxyglucose positron emission tomography/computed tomography in preoperative assessment of anterior mediastinal masses.
Luzzi L; Campione A; Gorla A; Vassallo G; Bianchi A; Biggi A; Terzi A
Eur J Cardiothorac Surg; 2009 Sep; 36(3):475-9. PubMed ID: 19501523
[TBL] [Abstract][Full Text] [Related]
19. Clinical use of combined positron emission tomography and computed tomography in thymoma recurrence.
El-Bawab HY; Abouzied MM; Rafay MA; Hajjar WM; Saleh WM; Alkattan KM
Interact Cardiovasc Thorac Surg; 2010 Oct; 11(4):395-9. PubMed ID: 20639307
[TBL] [Abstract][Full Text] [Related]
20. Utility of pre-treatment FDG PET/CT-derived machine learning models for outcome prediction in classical Hodgkin lymphoma.
Frood R; Clark M; Burton C; Tsoumpas C; Frangi AF; Gleeson F; Patel C; Scarsbrook A
Eur Radiol; 2022 Oct; 32(10):7237-7247. PubMed ID: 36006428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
